CDC Gives Final OK for COVID Vaccinations for Youngest Kids

June 18, 2022 — COVID-19 vaccines for children 6 months to 5 years of age are now ready to go. Centers for Disease Control Prevention (CDC) Director Rochelle, Walensky, MD, has endorsed a unanimous recommendation by the agency’s vaccine panel today, allowing vaccinations to begin early this week. The CDC’s Advisory Committee on Immunization Practices … Read more

FDA Authorizes First Covid-19 Vaccines for Young Children

Some 1½ years after first authorizing the shots for people of older ages, the Food and Drug Administration on Friday expanded use of the vaccines to the nearly 20 million children in the U.S. from 6 months to under 5 years. A national campaign to vaccinate the young children is expected to kick off as … Read more

WTO Nations Agree to Ease Patent Rights to Boost Covid-19 Vaccine Supplies in Poorer Nations

GENEVA—The member countries of the World Trade Organization agreed Friday on a narrow measure aimed at boosting the supplies of Covid-19 vaccines in developing countries, wrapping up a bitter fight over corporate patent rights governing critical medical products during a pandemic. The compromise measure on intellectual property rights will make it easier for companies in … Read more

FDA Panel Votes Unanimously for COVID Shots for Youngest Kids

June 15, 2022 – The benefits to America’s youngest children from COVID-19 vaccines far outweigh the negatives, an outside group of FDA advisors said Wednesday. The Vaccines and Related Biological Products Advisory Committee voted unanimously, 21-0, to recommend the use of Pfizer’s vaccines in kids 6 months through 4 years and and Moderna’s vaccine in … Read more

FDA Advisers Review Pfizer, Moderna Covid-19 Vaccines in Young Children

A positive recommendation would likely lead soon to expanding the U.S. Covid-19 vaccination campaign to the 19.6 million children ranging in age from 6 months to under 5 years old, one of the last groups of people in the U.S. waiting for shots. Moderna’s two-dose vaccine is up for the Food and Drug Administration’s authorization … Read more

FDA Should Authorize Moderna’s Vaccine for Ages 6 to 17, Advisers Say

A panel of advisers to the Food and Drug Administration recommended the agency expand use of Moderna Inc.’s Covid-19 vaccine to children ages 6 through 17. The advisory committee voted 22-0 on Tuesday that the benefits of vaccinating children in this age group outweigh the risks. The FDA will consider the vote in making a … Read more

FDA Set to Rule on COVID Shots for Youngest Kids This Week

June 13, 2022 — The FDA is gearing up for a busy week – after a busy weekend releasing information about the effectiveness and safety of both the Pfizer/BioNTech COVID-19 vaccine in children under 5 years old and the Moderna vaccine in children 6 months to 17 years of age. This data comes just before … Read more

Three-Dose Pfizer Covid Vaccine Works Safely in Young Children, Review Says

The FDA staff also said, in a review of study data posted online Sunday, that there were no new safety concerns using the vaccine in young children compared with older age groups. The assessment is the latest sign that authorities are moving closer to clearing inoculations for children under 5 years old, the last group … Read more

Moderna’s Covid-19 Vaccine Works Safely in Kids, Including Those Under Age 5, FDA Says

Moderna Inc.’s Covid-19 vaccine was effective at preventing symptomatic disease in children ages 6 months through 5 years, Food and Drug Administration staff said in a review of the evidence. The FDA staff also said Friday that Moderna’s vaccine was generally safe in children in studies, including those under 5 years who haven’t had access … Read more

Novavax’s Covid-19 Vaccine Backed by FDA Advisers

Vaccine experts advising the Food and Drug Administration endorsed Novavax Inc.’s Covid-19 vaccine, voting overwhelmingly that the shot’s benefits outweighed its risks. The FDA must next make a decision on authorizing the vaccine, after months of manufacturing-related delays and an agency review that found the shots effective but raised a safety concern. An FDA decision … Read more